Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,116 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,163)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07316361 | GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer(GYNORYLAQ™) | enrolling by invitation | Early Phase 1 | 40 | Biogenea Pharmaceuticals Ltd.INDUSTRY | 1 | Jan 7, 2026 | clinicaltrials |
| NCT07311070 | Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue | enrolling by invitation | Phase 3 | 20 | Daryoush Hamidi Alamdari, PhDOTHER |
| 1 |
| Jan 6, 2026 |
| clinicaltrials |
| NCT07312578 | Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma | enrolling by invitation | Phase 2 | 48 | Peking UniversityOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT06462521 | Cold Snare Piecemeal Resection vs Cold Snare Endoscopic Mucosal Resection(CARDINAL) | enrolling by invitation | N/A | 570 | Indiana UniversityOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07050485 | Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery | enrolling by invitation | N/A | 30 | University of South FloridaOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07306130 | Consensus on Skin Care in Breast Cancer Patients | enrolling by invitation | — | 15 | Venus Research CenterOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07307157 | Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review(COSMO) | enrolling by invitation | — | 30 | Harvard Medical School (HMS and HSDM)OTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT01385722 | Molecular Analysis of Thoracic Malignancies | enrolling by invitation | — | 1,000 | Stanford UniversityOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT07283627 | Exploring the Evolution of Quality of Life and Emotional Distress Among Cancer Patients Participating in Mind-body Therapies(MBT & cancer) | enrolling by invitation | — | 150 | La Tour HospitalOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT07301983 | Evaluation of Lymph Node Analysis Using One Step Nucleic Acid Amplification (OSNA) in Patients With Lung Cancer Who Underwent Robotic Lung Resection, Comparison With Traditional Methods(LALC) | enrolling by invitation | — | 130 | Azienda Ospedaliero, Universitaria PisanaOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT00186147 | Bone Marrow Grafting for Leukemia and Lymphoma | enrolling by invitation | — | 9,999 | Stanford UniversityOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT03793335 | Individually Tailored Strategies for the Precision Prevention of Gastric Cancer and Colorectal Cancer in the Community | enrolling by invitation | — | 40,000 | National Taiwan University HospitalOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT07290764 | Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy | enrolling by invitation | — | 729 | Fujian Provincial HospitalOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT04945317 | ROSE for Improved Molecular Marker Testing Via EBUS(ROSE/NoROSE) | enrolling by invitation | N/A | 349 | Johns Hopkins UniversityOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT07289568 | Surgical Outcomes in Splenic Flexure Cancers: A Multicenter Comparison of Segmental vs. Extended Hemicolectomy (SPARROW Study)(SPARROW) | enrolling by invitation | — | 140 | Acibadem UniversityOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT07285434 | Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer(Microlyvaq™) | enrolling by invitation | Early Phase 1 | 90 | Biogenea Pharmaceuticals Ltd.INDUSTRY | 1 | Dec 16, 2025 | clinicaltrials |
| NCT07100054 | Pharmacogenomic and Circulating Biomarkers for CDK4/6 Inhibitors | enrolling by invitation | — | 100 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Dec 12, 2025 | clinicaltrials |
| NCT06227962 | Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors(RbNeuroQoL) | enrolling by invitation | — | 240 | Amsterdam University Medical CenterOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT07264296 | Implant-Related Infections in Patients With Skeletal Sarcomas(IRISSAR) | enrolling by invitation | — | 40 | Vastra Gotaland RegionOTHER_GOV | 1 | Dec 4, 2025 | clinicaltrials |
| NCT06269744 | Proactive Outreach With FIT(PROOF) | enrolling by invitation | N/A | 3,000 | NYU Langone HealthOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07258680 | BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line Therapy of T-cell Lymphomas(BrEto-TCL) | enrolling by invitation | Phase 3 | 114 | N.N. Petrov National Medical Research Center of OncologyOTHER | 0 | Dec 2, 2025 | clinicaltrials |
| NCT06843681 | Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study | enrolling by invitation | Phase 2 | 54 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT07173790 | Watch and Wait or Worry and Wait in Indolent Lymphoma | enrolling by invitation | — | 250 | Seoul National University HospitalOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT07241676 | Early Recurrence After Surgery for Pancreatic Cancer(POCEMON BLUE) | enrolling by invitation | — | 500 | Azienda Ospedaliera di PadovaOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT07230795 | AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake | enrolling by invitation | N/A | 7,120 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT02270567 | RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide(RegisterNET) | enrolling by invitation | — | 400 | Wren Laboratories LLCINDUSTRY | 1 | Nov 13, 2025 | clinicaltrials |
| NCT06544798 | Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia | enrolling by invitation | Phase 2 | 276 | MeiraGTx, LLCINDUSTRY | 2 | Oct 16, 2025 | clinicaltrials |
| NCT06298149 | Reach Through Equitable Implementation of Turtle Island Tales | enrolling by invitation | N/A | 200 | Montana State UniversityOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT07206888 | Advanced Ultrasound Signal Processing of Suspicious Breast Images(AUSPICIOUS) | enrolling by invitation | — | 252 | Johns Hopkins UniversityOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT04954625 | Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial | enrolling by invitation | N/A | 60 | Rush University Medical CenterOTHER | 1 | Oct 10, 2025 | clinicaltrials |
| NCT07214441 | Evaluating the Feasibility and Preliminary Effects of BE+ | enrolling by invitation | N/A | 20 | University of South CarolinaOTHER | 1 | Oct 9, 2025 | clinicaltrials |
| NCT04539717 | FAST (Focused Abbreviated Screening Technique)-MRI Study | enrolling by invitation | — | 820 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT07014462 | A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naïve Acute Myeloid Leukemia (AML): DLIT-AML(DLIT-AML) | enrolling by invitation | Phase 1 | 20 | University of VermontOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT03244020 | LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology | enrolling by invitation | Phase 4 | 2,868 | Massachusetts General HospitalOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT07121478 | Patients With High-grade Pancreatic Neuroendocrine Tumors | enrolling by invitation | Phase 2 | 46 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 1, 2025 | clinicaltrials |
| NCT06674538 | Clinical Trial to Treat Stage IV Cancer Patients | enrolling by invitation | Phase 1 | 12 | Moonshot AntibodiesINDUSTRY | 1 | Sep 22, 2025 | clinicaltrials |
| NCT07176455 | Temporal Transformation Mechanism and Intervention Strategies of Frail-related Dietary Behaviors in Older Gastric Cancer Survivors | enrolling by invitation | — | 438 | Nanjing Medical UniversityOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT06882876 | JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study | enrolling by invitation | Phase 1 | 20 | Xiangya Hospital of Central South UniversityOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT06942286 | Primary HPV Self-Collection in Indonesia | enrolling by invitation | N/A | 8,000 | Dharmais National Cancer Center HospitalOTHER_GOV | 1 | Sep 17, 2025 | clinicaltrials |
| NCT05893654 | Melphalan Chemoreduction for Ocular Melanoma(MELCOM) | enrolling by invitation | Phase 1 / Phase 2 | 10 | Hospital das Clínicas de Ribeirão PretoOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07171515 | Development & Clinical Application of K-PaC Registry Version 2.0 | enrolling by invitation | — | 6,923 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 12, 2025 | clinicaltrials |
| NCT05739071 | JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer | enrolling by invitation | N/A | 100 | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT06931860 | Head to Head Trial of Mailed Cologuard to Mailed FIT | enrolling by invitation | N/A | 400 | University of California, San DiegoOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT07155616 | NON-INVASIVE BLOOD FLOW ASSESSMENT: Computational Tool for Measuring Arterial Flow From CT(NOVELLA) | enrolling by invitation | — | 100 | Hospital Clinic of BarcelonaOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT01460264 | An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study(BIG3) | enrolling by invitation | — | 10,000 | Region SkaneOTHER | 1 | Aug 29, 2025 | clinicaltrials |
| NCT07129005 | Radiomics-Based Non-Invasive MRI Differentiation of Uterine Sarcomas and Fibroids | enrolling by invitation | — | 520 | Tongji HospitalOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT07130149 | Sonodynamic-Chemoradiotherapy Integration in Glioblastoma | enrolling by invitation | Phase 2 | 230 | Yingjuan ZhengOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT05385861 | Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET | enrolling by invitation | Phase 1 / Phase 2 | 52 | National Health Research Institutes, TaiwanOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT06424275 | Prostate Cancer Awareness and Initiative for Screening in the European Union(PRAISE-U) | enrolling by invitation | — | 20,000 | European Association of Urology Research FoundationOTHER | 4 | Aug 15, 2025 | clinicaltrials |
| NCT06941818 | HS-IT101 Injection in the Treatment of Advanced Melanoma | enrolling by invitation | Phase 1 | 10 | Qingdao Sino-Cell Biomedicine Co., Ltd.INDUSTRY | 1 | Aug 14, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jan 7, 2026source: clinicaltrials